Associated Papers
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
41152984 (PubMed )
Supplement: 13073_2025_1564_MOESM2_ESM.xlsx › Table_S6
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review.
Vaghi C et al.
Cancer Treatment Reviews, 2023
HER2+ mCRC patients with exon 20 R784G substitution mutation do not respond to the cetuximab therapy.
Gharib E et al.
Journal of Cellular Physiology, 2019
Select a paper to view details